M. Godschalk et al., LONG-TERM EFFICACY OF A NEW FORMULATION OF PROSTAGLANDIN-E1 AS TREATMENT FOR ERECTILE FAILURE, The Journal of urology, 155(3), 1996, pp. 915-917
Purpose: We determined the long-term efficacy of intracavernous inject
ion of a new formulation of prostaglandin E1 (Caverject) as treatment
for erectile failure. Materials and Methods: A prospective study was
done at a university affiliated Veterans Affairs medical center. Subje
cts with erectile failure received injections of prostaglandin E1 at t
he office and self-administered injections at home for up to 18 months
. Results: Of 16 patients who performed home injections 15 completed 6
months and 10 completed 18 months of therapy. Patient and spousal sat
isfaction with intercourse was 90% for months 1 to 6, and patient sati
sfaction was 95% for months 7 to 18. Conclusions: Prostaglandin E1 was
highly effective at producing penile rigidity and an erection with sa
tisfactory vaginal intercourse.